Routine pneumococcal conjugate vaccination in developing countries can contribute to achieving the United Nations' Millennium Development Goal to decrease childhood deaths by two-thirds by 2015.

Routine pneumococcal conjugate vaccination in developing countries can contribute to achieving the United Nations' Millennium Development Goal to decrease childhood deaths by two-thirds by 2015.

News

The latest news from GAVI’s PneumoADIP and recent developments in combating pneumococcal disease including: PneumoFOCUS our monthly newsletter, news from the field, press releases, recent media coverage profiling PneumoADIP and our work, and upcoming events.

PneumoFOCUS

The PneumoADIP communications team produces and distributes a monthly newsletter, PneumoFOCUS, dedicated to all sector news about pneumococcal disease and pneumococcal vaccines.

Click here to read the latest issue of PneumoADIP's monthly newsletter.

News from the Field

Read interviews and updates from PneumoADIP colleagues from around the world.

Press Releases

Read the latest PneumoADIP press releases

PneumoADIP in the News

The latest news coverage profiling PneumoADIP

Upcoming Events

Click here for an overview of upcoming events and meetings related to pneumococcal disease, vaccination and global health

Media Contacts

Contact details for media enquiries

The Pneumococcal vaccines Accelerated Development and Introduction Plan is based
at Johns Hopkins Bloomberg School of Public Health and is funded by GAVI Alliance.